Notably, NOTCH1 expression was higher in benign tumors compared to precancerous and malignant tumors, whereas FGFR2 expression showed an opposite trend, with higher levels in precancerous and malignant tumors compared to benign tumors. The gene discussed is FGFR2; the disease is cancer.